Explorer les evidences

2 patientsSmoking addiction was present in two patients.

Côte d'Ivoiresmoking addictionpublié 2009Antiviral therapyeurope_pmcdocument de 11 observations

67,7 %21 (67.7%) HIV-2 patients switched at least one antiretroviral drug.

Côte d'IvoireVIH/sidapublié 2020PloS oneeurope_pmcdocument de 13 observationsDOI 10.1371/journal.pone.0236642

341 /mm³Median CD4+ T-cell count was 341/mm³ among 491 adult HIV patients.

Côte d'IvoireVIH/sidaobservé 2006publié 2012World journal of hepatologyeurope_pmcdocument de 13 observations

69 casesThe most frequently reported countries of contamination were Ivory Coast (n = 69; 25.9%), Democratic Republic of the Congo (n = 64; 24.1%), and Cameroon (n = 35; 13.2%).

Côte d'IvoirepaludismeHAL · Unilimdocument de 123 observations

4 %Ten (4%) of patients in the raltegravir group experienced AIDS-defining illnesses.

Côte d'IvoireAIDS-defining illnessespublié 2021The Lancet. Infectious diseaseseurope_pmcdocument de 11 observationsDOI 10.1016/s1473-3099(20)30869-0

48 %Among hospitalized HIV-positive adults in West Africa, 48% had previously received antiretroviral treatment.

Côte d'IvoireVIH/sidaobservé 2010publié 2014Journal of the International AIDS Societyeurope_pmcdocument de 22 observationsDOI 10.7448/ias.17.1.18797

5,2 log10_copies_per_mlMedian HBV DNA level was 5.2 log(10) copies/ml for patients with chronic hepatitis B.

Côte d'Ivoirehépatite Bpublié 2010Antiviral therapyeurope_pmcdocument de 7 observations

73,3 %73.3% of 491 adult HIV patients were female.

Côte d'IvoireVIH/sidaobservé 2006publié 2012World journal of hepatologyeurope_pmcdocument de 13 observations

15,5 per_100_person_yearsThe incidence of malaria was 15.5 per 100 person-years in the non-CTX group.

Côte d'Ivoirepaludismepublié 2017Tropical medicine & international health : TM & IHeurope_pmcdocument de 4 observationsDOI 10.1111/tmi.12919

69 %HIV-2 resistance mutations to protease inhibitors were detected in 20 of 29 (69%) samples.

Côte d'IvoireVIH/sidapublié 2014AIDS (London, England)europe_pmcdocument de 9 observations

1 754 patientsThe study included 1,754 HIV-2 and HIV-1/HIV-2 dually seropositive patients.

Côte d'IvoireVIH/sidapublié 2013PloS oneeurope_pmcdocument de 14 observations

3,6 %A seropositivity to HIV1 and/or HIV2 was observed in 9 (3.6%) of 246 pregnant women in Ivory Coast from January to December 1987.

Côte d'IvoireHIV1 and/or HIV2observé 1987publié 1989PubMedOpenAlexdocument de 10 observations

73,33 %La fréquence de la neuropathie périphérique était de 73,33 % chez les personnes diabétiques en Côte d'Ivoire selon l'étude de Cowppli-Bony P et al (2004).

Côte d'Ivoirediabète (non précisé)observé 2004HAL · Unilimdocument de 747 observations

100 %Infection prevalence was 100.0% in Survey 1 among 732 participants.

Côte d'IvoirepaludismeHAL · Unilimdocument de 122 observations

45,3 yearsAt ART initiation, the median age of HIV-2 patients was 45.3 years.

Côte d'IvoireVIH/sidapublié 2013PloS oneeurope_pmcdocument de 14 observations

66 %Among the 220 patients receiving ART, 145 (66.0%) had CD4-T cell count ≤ 500 cells/mm3.

Côte d'IvoireVIH/sidaobservé 2012publié 2015PloS oneeurope_pmcdocument de 9 observations

2,6 %Among patients receiving ART with CD4-T cell count ≥ 500 cells/mm3, 2 (2.6%) had VL >100 cps/mL.

Côte d'IvoireVIH avancéobservé 2012publié 2015PloS oneeurope_pmcdocument de 9 observations

128 consultationsFrom January 1st, 2000 to December 31st, 2007, 128 consultations for non-occupational HIV exposure were managed in the Abidjan infectious diseases department.

Côte d'IvoireVIH/sidaobservé 2000-2007publié 2010Medecine et maladies infectieuseseurope_pmcdocument de 13 observations

8,3 per_100_person-yearsThe incidence of first serious event among HIV-infected adults receiving antiretroviral treatment was 8.3 per 100 person-years thereafter.

Côte d'IvoireVIH/sidapublié 2013BMC infectious diseaseseurope_pmcdocument de 10 observationsDOI 10.1186/1471-2334-13-607

20,4 %Of 457 participants included in this study, 90 (20.4%) had grade 2 + or 3 + smear positivity.

Côte d'Ivoiretuberculosepublié 2025BMC infectious diseaseseurope_pmcdocument de 9 observations

551 patientsAmong HIV-2 infected patients, 551 were on antiretroviral therapy (ART).

Côte d'IvoireVIH/sidapublié 2013PloS oneeurope_pmcdocument de 14 observations

24,7 %Of 457 participants included in this study, 113 (24.7%) presented severe morbidity.

Côte d'Ivoiretuberculosepublié 2025BMC infectious diseaseseurope_pmcdocument de 9 observations

854 casesBetween December 2016 and August 2018, 854 confirmed malaria cases were recorded over 84,446 theoretical person-months of follow-up.

Côte d'Ivoirepaludismeobservé December 2016 to August 2018HAL · Unilimdocument de 54 observations

118 cells/μLThe mean CD4 cell count increase at month-12 among HIV-2 infected patients on antiretroviral therapy was +118 cells/μL.

Côte d'IvoireVIH/sidaobservé month-12publié 2014BMC infectious diseaseseurope_pmcdocument de 3 observationsDOI 10.1186/1471-2334-14-461

4 %Among 66 patients with non-clinical HIV risk indicators, only 11 (4.0%) mentioned it to a health professional.

Côte d'IvoireVIH/sidaobservé 2013–2014publié 2017PloS oneeurope_pmcdocument de 5 observations